SMITHKLINE BEECHAM PAXIL U.S. SALES REACH $135 MIL. IN FIRST 10 MONTHS ON MARKET; COMPANY's 1993 U.S. PHARMACEUTICAL SALES INCREASE 11% TO $2.42 BIL.